Novartis AG NVS:NYSE

RT Quote | Last NYSE, VOL From CTA | USD
Last | 12:24 PM EDT
76.40quote price arrow up+0.39 (+0.51%)
Volume
946,702
52 week range
74.09 - 94.26
Loading...
  • Open76.88
  • Day High76.92
  • Day Low76.29
  • Prev Close76.01
  • 52 Week High94.26
  • 52 Week High Date04/11/22
  • 52 Week Low74.09
  • 52 Week Low Date09/26/22

Key Stats

  • Market Cap183.644B
  • Shares Out2.404B
  • 10 Day Average Volume3.15M
  • Dividend3.33
  • Dividend Yield4.35%
  • Beta0.54
  • YTD % Change-12.56

KEY STATS

  • Open76.88
  • Day High76.92
  • Day Low76.29
  • Prev Close76.01
  • 52 Week High94.26
  • 52 Week High Date04/11/22
  • 52 Week Low74.09
  • 52 Week Low Date09/26/22
  • Market Cap183.644B
  • Shares Out2.404B
  • 10 Day Average Volume3.15M
  • Dividend3.33
  • Dividend Yield4.35%
  • Beta0.54
  • YTD % Change-12.56

RATIOS/PROFITABILITY

  • EPS (TTM)10.21
  • P/E (TTM)7.48
  • Fwd P/E (NTM)12.16
  • EBITDA (TTM)18.952B
  • ROE (TTM)39.30%
  • Revenue (TTM)52.788B
  • Gross Margin (TTM)70.92%
  • Net Margin (TTM)43.53%
  • Debt To Equity (MRQ)49.31%

EVENTS

  • Earnings Date10/25/2022(est)
  • Ex Div Date03/08/2022
  • Div Amount3.3252
  • Split Date-
  • Split Factor-

Related Video

CNBC Pro Talks: Fast Money trader Tim Seymour on how to play an uncertain market heading into Fall
VIDEO54:4954:49
CNBC Pro Talks: Tim Seymour on how to play an uncertain market heading into Fall

Profile

MORE
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided...
Joerg Reinhardt Ph.D.
Independent Non-Executive Chairman of the Board
Vasant Narasimhan M.D.
Chief Executive Officer, Member of the Executive Committee
Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Address
Lichtstrasse 35
Basel
4056
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
AZN
AstraZeneca PLC
55.28+0.44+0.80%
BMY
Bristol-Myers Squibb Co
70.37-0.72-1.01%
MRK
Merck & Co Inc
86.58+0.46+0.53%
ABBV
Abbvie Inc
137.96+3.75+2.79%
SNY
Sanofi SA
39.14+1.12+2.95%